Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke
Clinical trial NCT03763929 · TERMINATED
Trial details
- NCT number
- NCT03763929
- Sponsor
- Diffusion Pharmaceuticals Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-22
- Primary completion
- 2020-10-19
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.